These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26392022)

  • 21. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitization: achieving immune detente.
    Zachary AA; Eng HS
    Tissue Antigens; 2011 Jan; 77(1):3-8. PubMed ID: 21155718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates.
    Reinsmoen NL; Lai CH; Vo A; Jordan SC
    Discov Med; 2012 Apr; 13(71):267-73. PubMed ID: 22541614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the histocompatibility laboratory in desensitization for transplantation.
    Leffell MS; Zachary AA
    Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
    Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
    Appel JZ; Hartwig MG; Davis RD; Reinsmoen NL
    Hum Immunol; 2005 Apr; 66(4):378-86. PubMed ID: 15866701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.
    Montgomery RA; Lonze BE; Jackson AM
    Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?
    Howsare M; Jones CM; Ramirez AM
    Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA in transplantation.
    Montgomery RA; Tatapudi VS; Leffell MS; Zachary AA
    Nat Rev Nephrol; 2018 Sep; 14(9):558-570. PubMed ID: 29985463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascularized Composite Allotransplantation: Alternatives and Catch-22s.
    Diaz-Siso JR; Borab ZM; Plana NM; Parent B; Stranix JT; Rodriguez ED
    Plast Reconstr Surg; 2018 Nov; 142(5):1320-1326. PubMed ID: 30511987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
    Kimball PM; McDougan FA; King A
    Clin Transpl; 2014; ():197-203. PubMed ID: 26281145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation - a retrospective study.
    Weissenbacher A; Vrakas G; Chen M; Reddy S; Allan P; Giele H; Barnardo MCNM; Vaidya A; Friend PJ; Fuggle SV
    Transpl Int; 2018 Apr; 31(4):398-407. PubMed ID: 29150964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desensitization in heart transplant recipients: Who, when, and how.
    Shah KS; Patel J
    Clin Transplant; 2019 Aug; 33(8):e13639. PubMed ID: 31206862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.
    Hautz T; Zelger BG; Nasr IW; Mundinger GS; Barth RN; Rodriguez ED; Brandacher G; Weissenbacher A; Zelger B; Cavadas P; Margreiter R; Lee WP; Pratschke J; Lakkis FG; Schneeberger S
    Transpl Int; 2014 Sep; 27(9):966-76. PubMed ID: 24853399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.